IgY antibody technology against SARS-CoV-2 unveiled
An IgY neutralizing antibody, which is claimed to inhibit the activity of SARS-CoV-2, the novel coronavirus that causes COVID-19, by
Labnovation’s COVID-19 ART Test Kit Approved by the FDA of the Philippines for Self-Testing
Singapore, Asia’s integrated healthcare company, Clearbridge Health Limite is pleased to announce that Labnovation Technologies, Inc.’s (“Labnovation”) COVID-19 Antigen Rapid (“ART”)
Indegene expands global operations with new nearshore centers in Americas and Europe
PRINCETON, N.J. and BANGALORE, India, Indegene, a technology-led healthcare solutions provider today announced it established new Global Development Centers in
Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab
Waltham, Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced positive topline results from
Fermenta has signed a Definitive Agreement with Aurigene, a stepdown subsidiary of Dr Reddy’s Laboratories Limited
Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a
Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases
BARCELONA, Spain, a global biopharmaceutical company focused on skin health, and IRB Barcelona (the Institute for Research in Biomedicine), an independent,